This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to Booz Allen Hamilton Inc., a leading management and technology consulting firm, for the implementation of the FDA Safety and Innovation Act (FDASIA) Human Drug Review. The $8,985,714.89 award is a Blanket Purchase Agreement (BPA) call and covers a range of services including cybersecurity, data analytics, and operational support for the FDA's human drug review processes. The contract is not set aside.
Major subcontractors include Tailored Solutions & Consulting Inc., an SDVOSB cybersecurity firm, and Emprata LLC, a small business providing IT consulting services. These subcontractors are supporting the implementation of FDASIA by delivering capabilities such as cybersecurity data requirements, threat modeling, compliance monitoring, and software assurance. The overall FDASIA Support Services contract vehicle was previously established by the FDA to streamline procurement of critical services related to the agency's drug review and approval functions.
Generated 3/24/24, 5:12 AM